The use of an Ascents® clinical aromatherapy formula -- Calm No. 34 -- improved negative affect in a new, joint virtual reality-assisted art therapy study carried out by two major American universities. The study was published in Frontiers in Psychology, one of the foremost peer-reviewed scientific journals dedicated to mental health. Ascents’ Calm formula features an evidence-based, proprietary blend of essential oils proven to reduce stress and anxiety in clinical research.
CLEVELAND (PRWEB) DECEMBER 18, 2020
A new joint study from Johns Hopkins University and Drexel University demonstrates that Ascents® Clinical Aromatherapy’s Calm No. 34 essential oil formula can improve negative affect (mood). Calm features an evidence-based, proprietary blend of essential oils proven to reduce stress and anxiety in clinical research.
About the Study
Entitled “Outcomes of Visual Self-Expression in Virtual Reality on Psychosocial Well-Being With the Inclusion of a Fragrance Stimulus: A Pilot Mixed-Methods Study,” the paper examines participants’ experiences of engaging in virtual drawing tasks and the impact of an olfactory stimulus -- Ascents’ proprietary Calm formula -- on stress, self-efficacy, anxiety, creative agency, well-being (life satisfaction) and affect. The study was published in Frontiers in Psychology, one of the foremost peer-reviewed scientific journals dedicated to mental health. “What this proves, once again, is the incredible power of scent to influence feelings and behavior,” says Mark Kohoot, CEO of Aeroscena®, the parent company behind Ascents-brand aromatherapy. “The fact that scent can significantly improve mood has enormous implications for everything from psychology and medicine to personal fragrance and home care.”
About the Study's Results
The quantitative results demonstrated a significant reduction in negative affect (e.g., feeling hostile, jittery, upset, distressed, etc.), namely reduced feelings of negativity, in the study condition using the Ascents Calm clinical aromatherapy formula, when compared to the non-fragrance condition. A trend toward improvement in self-efficacy was also seen in the Ascents-fragranced condition. The study’s authors concluded that this type of fragrance, presented using whole-room diffusion, can enhance participants’ therapeutic experiences. They went on to suggest that future studies examine the effect of other types of scents aimed at promoting focus and concentration -- an area of concern that Aeroscena has addressed via its Ascents Focus No. 04 essential oil formula, and with which the company hopes to conduct future clinical research.
About Aeroscena®, LLC
Established in 2010, Aeroscena is the corporate research and development organization behind Ascents®-brand clinical aromatherapy. Aeroscena has designed the first scientifically-recognized platform for essential oil and aromatherapy R&D for their use as medical interventions (phytoceuticals; plant-based pharmaceuticals) and in CPG products (natural, functional fragrance). Aeroscena is located in the Cleveland Clinic Global Cardiovascular Innovations Center in Cleveland, OH. For more information about Ascents, visit https://shopascents.com. For more information about Aeroscena®, visit https://aeroscena.com.